Effect of insoluble matrixformers on trimetazidine dihydrochloride in vitro release from matrix tablets

Journal Title: Фармацевтичний журнал - Year 2015, Vol 3, Issue 3

Abstract

Oral matrix tablet is a modern dosage form using which could be achieved desirable in vitro dissolution profile of API and correspondent in vivo API concentration level. Therefore, the study of factors that affect in vitro dissolution profile of API is the actual task. The aim of this work was study of insoluble matrix formers with different molecular structure and physicochemical properties effect on in vitro dissolution profile of API. The object of this study were the matrix tablets with Eudragit RSPO, Kollidon SR, Precirol ATO 5, Ethocel 10 matrix formers and trimetazidine dihydrochloride (TMZ•2HCl) as model substance. Laser light scattering method‎ for particles size measurement and direct compression method for tablets preparation, Dissolution method for determination of TMZ•2HCl in vitro release kinetic, tablets drying to constant weight at 105 °С and gravimetric weighting for lost of dry determination, diameter and height measurement using caliper for tablet’s volume determination, there used. Polyvinyl acetate films were prepared for Kollidon SR matrix former behavior investigation: the film from Kollicoat SR 30D was prepared using film casting method and followed by drying at 70 °С, the film from Kollidon SR only was prepared using hydraulic hand press. The study showed that the ability of matrix formers to slow down of TMZ•2HCl release from matrix tablets in pH 1 and pH 6.8 medium is arranged in the same sequence: Ethocel 10 > Precirol ATO 5 > Kollidon SR > Eudragit RSPO. Was established that the matrix tablets with Kollidon SR and Eudragit RSPO are swell considerably in comparison with Ethocel 10 and Precirol ATO 5 which is consistent with their chemical structure. The specific moisture content decreasing of matrix tablets during the "dissolution" test in accordance with their matrix formers is arranged in the follow sequence: Kollidon SR > Eudragit RSPO > Precirol ATO 5 > Ethocel St. 10 FP. In contrast to Kollicoat SR film swelling was found that Kollidon SR matrix system swelling occurs due to the Kollidon SR particles elastic recovery of spherical shape and size increasing during polyvinyl acetate hydration.

Authors and Affiliations

V. V. Mohylyuk, L. L. Davtyan

Keywords

Related Articles

HPLC-determination of active components in dietary supplement «L-CARNITINE smart»

Dietary supplements are compositions of biologically active substances intended for consumption with food or addition to food products for the purpose of optimization of metabolic processes and functions of the human bod...

Study of turnover extemporaneous preparations in Ukraine on the basis of pharmaceutical law

In today's environment is a topical issue of improving the treatment system extemporaneous preparations in the framework of relations «doctor–patient–pharmacist» as part of the standards of good pharmacy practice (Good P...

Integrated use of the bark of spindle tree (Euonymus europaea L.). investigation of lipophilic substances

The bark and fruit of European spindle tree (Euonymus europaea L.) has long been used in folk medicine as an anthelmintic, anti-insecticide, as well as for treatment ringworm and eczema. However, what substances responsi...

Analysis of the dynamics structure of National formulary of medicines

For effective functioning in modern conditions the Concept of rational use of medicines, formulated by the WHO's initiative in 1985, requires cooperation of three basic components: the formulary system, the list of essen...

Provision for patients with hypertension on access to cost compensation of essential drugs

Hypertensive heart disease is one of the important factors that lead to an increase in the number of deaths and reduce the forecast life expectancy of patients with essential hypertension. The aim of the research was th...

Download PDF file
  • EP ID EP583384
  • DOI -
  • Views 38
  • Downloads 0

How To Cite

V. V. Mohylyuk, L. L. Davtyan (2015). Effect of insoluble matrixformers on trimetazidine dihydrochloride in vitro release from matrix tablets. Фармацевтичний журнал, 3(3), 26-33. https://europub.co.uk/articles/-A-583384